Literature DB >> 25707921

Characteristics of men classified at high-risk for type 2 diabetes mellitus using the AUSDRISK screening tool.

Elroy J Aguiar1, Philip J Morgan2, Clare E Collins3, Ronald C Plotnikoff4, Robin Callister5.   

Abstract

AIMS: The primary aim was to describe characteristics of men identified at high-risk for Type 2 diabetes mellitus (T2DM) using the Australian diabetes risk assessment (AUSDRISK) tool. Secondary aims were to determine the prevalence of pre-diabetes and metabolic syndrome in these men.
METHODS: Men (n=209) completed the AUSDRISK tool, with 165 identified as high-risk for T2DM (score ≥ 12, maximum 38). Demographic, anthropometric, physiological and behavioural outcomes were assessed for 101 men. Comparisons (one-way ANOVA) among three AUSDRISK score groups (12-15, 16-19, ≥ 20) were performed (significance level, P<0.05).
RESULTS: Common risk factors (percentages) among high-risk men were waist circumference (>90 cm; 93%), age (>44 years; 79%), physical activity level (< 150 min wk(-1); 59%), family history of diabetes (39%) and previously high blood glucose levels (32%). Men with AUSDRISK scores ≥ 20 had higher (mean ± SD) HbA1C (6.0 ± 0.4% [42 ± 4.4 mmol.mol(-1)], P<0.001), FPG (5.3 ± 0.6 mmol.L(-1), P=0.001) and waist circumference (113.2 ± 9.8 cm, P=0.026) than men with scores of 12-15. Mean FPG for the sample was 5.0 ± 0.6 mmol.L(-1), whereas mean HbA1C was 5.8 ± 0.5% [40 ± 5.5 mmol.mol(-1)]. Pre-diabetes prevalence was 70% and metabolic syndrome prevalence was 62%.
CONCLUSIONS: The AUSDRISK tool identified men who were mostly older than 44, and had large waist circumferences and elevated HbA1C. These findings provide evidence supporting the usefulness of the AUSDRISK screening tool for T2DM screening in clinical and research settings.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fasting plasma glucose; HbA(1C); Prevention; Screening; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 25707921     DOI: 10.1016/j.diabres.2015.01.017

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  Process Evaluation of the Type 2 Diabetes Mellitus PULSE Program Randomized Controlled Trial: Recruitment, Engagement, and Overall Satisfaction.

Authors:  Elroy J Aguiar; Philip J Morgan; Clare E Collins; Ronald C Plotnikoff; Myles D Young; Robin Callister
Journal:  Am J Mens Health       Date:  2017-04-19

2.  The clinical utility of the AUSDRISK tool in assessing change in type 2 diabetes risk in overweight/obese volunteers undertaking a healthy lifestyle intervention.

Authors:  Allison Martin; Elizabeth P Neale; Linda C Tapsell
Journal:  Prev Med Rep       Date:  2018-11-30

3.  Noninvasive Prototype for Type 2 Diabetes Detection.

Authors:  Javier Ferney Castillo García; Jesús Hamilton Ortiz; Osamah Ibrahim Khalaf; Adrián David Valencia Hernández; Luis Carlos Rodríguez Timaná
Journal:  J Healthc Eng       Date:  2021-11-09       Impact factor: 2.682

4.  What is the effectiveness of a personalised video story after an online diabetes risk assessment? A Randomised Controlled Trial.

Authors:  Susan L Williams; Quyen To; Corneel Vandelanotte
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.